Navigation Links
OCuSOFT Refutes Comparison Time-Kill Study Released by Advanced Vision Research
Date:10/11/2007

RICHMOND, Texas, Oct. 11 /PRNewswire/ -- (SEND2PRESS NEWSWIRE) -- OCuSOFT Inc., producer of the popular ocular-lid hygiene products, OCuSOFT(R) Lid Scrub(TM) and OCuSOFT(R) Lid Scrub(TM) PLUS, is responding to a recent advertisement released by Advanced Vision Research (AVR) that was found to be misleading.

*(LOGO 72dpi: Send2Press.com/mediaboom/07-0803-Occusoft_72dpi.jpg)

The study, a bacteria time-kill analysis, compared OCuSOFT's Lid Scrub(TM) PLUS Eyelid Cleanser to AVR's SteriLid(R). However, according to OCuSOFT's Executive Vice President, Patrick Witham, "comparing the bacteria kill rate for these two products based on 30-second time point is like comparing apples to oranges." In addition, no evidence was found in AVR's analysis that results were based on independent-lab setting tests.

While both products are eyelid cleansers, they differ in their application and the time in which each product achieves maximum effectiveness. OCuSOFT(R) Lid Scrub(TM) PLUS can be used as a leave-on therapy, while SteriLid(R), according to manufacturer instructions, should be left in place for 60-seconds to achieve maximum effectiveness.

The AVR advertisement compared OCuSOFT(R) Lid Scrub(TM) PLUS and SteriLid(R) at the 30-second time point.

"Unlike SteriLid(R), OCuSOFT(R) Lid Scrub(TM) PLUS was never intended to achieve maximum effectiveness at 30-seconds," Witham said.

OCuSOFT conducted their own study, performed by an independent laboratory, Antimicrobial Test Laboratories, LLC, which tested OCuSOFT(R) Lid Scrub(TM) PLUS after 60-seconds, 60-minutes and 120-minutes. Bacteria reductions were greatest at contact times corresponding with instructions for "leave-on" application. At 120-minutes, at least a 99.9% bacteria reduction was realized on all bacteria, and for some, as much as 99.99%.

For comprehensive, independent laboratory study results, visit: http://www.ocusoft.com/studies/studyresults.html.

"For a true comparison," Witham explained, "AVR should have compared OCuSOFT(R) Lid Scrub(TM) PLUS at the 120-minute time point to SteriLid(R) at the 60-second time point." They would have found that OCuSOFT(R) is more effective.

OCuSOFT(R) Lid Scrub(TM) PLUS was developed with an understanding that most patients, and even health care providers, will not spend 60-seconds applying a solution and rinsing it off.

Emily Sickbert-Bennet, a public health epidemiologist with the University of North Carolina Health Care System and the UNC School of Public Health conducted a study that illustrates that, on average, health care providers spend less than 10-seconds scrubbing their hands.

"This is important information that should not be dismissed. The parallels that can be drawn between these hygiene regimens speak volumes about the likelihood of a patient realistically complying with a 60-second eyelid scrubbing regimen," Witham said. "We developed this practically non- irritating formula in an effort to increase patient compliance. What good is served by recommending a regimen that patients will not adhere to?"

OCuSOFT, Inc. specializes in ophthalmic research, development and supply to ophthalmologists and optometrists. They address clinical needs through well-researched and technological solutions, while improving patient compliance.

For a free sample of OCuSOFT(R) Lid Scrub(TM) PLUS, click: http://www.ocusoft.com/sample1.html. For more information about the company and their products, visit: http://www.ocusoft.com.

All trademarks acknowledged.

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com


'/>"/>
SOURCE OCuSOFT Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Study Refutes Theory on HIVs Effect on White Blood Cells
2. Comparison between warfarin and aspirin
3. Clinical Comparisons Between ADHD Drugs Are Less
4. Differences in brain pattern among liars and cheats in comparison to honest people
5. Rural Canadians travel far for specialists: study
6. A new study surpasses Gene Therapy Hurdle
7. Tomato Sauce reduces Cancer Risk- Study
8. A question on study of Adult Stem Cell
9. Study on obesity and heart failure
10. National Lung Study in the process
11. Marijuana gateway theory strengthened by study of twins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy ... in the United States and Canada wear eyeglasses. Once considered to be a purely ... make a fashion statement. Even celebrities use glasses as a way of creating an ...
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
Breaking Medicine Technology: